Hisham Ba'albaki
Cardiovascular Disease · Florence, ALNPI 1518029354
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,358 and has fallen 98.0% since, to $27 in 2024.
Across 217 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$555
- Amarin Pharma, Inc.$506
- Novartis$417
- Pfizer$361
- Johnson & Johnson$319
- Abbott$273
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,72998%
- Education$652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 34 | $555 |
| Amarin Pharma, Inc. | 30 | $506 |
| Novartis | 25 | $417 |
| Pfizer | 24 | $361 |
| Johnson & Johnson | 18 | $319 |
| Abbott | 8 | $273 |
| Merck | 15 | $271 |
| Amgen | 20 | $260 |
| Lundbeck LLC | 11 | $243 |
| Boehringer Ingelheim | 7 | $131 |
| Sanofi-aventis U.S. LLC | 5 | $97 |
| Chiesi USA, Inc. | 3 | $75 |
| Nuwellis, Inc. | 2 | $43 |
| Medtronic(2 entities) | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 3 | $36 |
| Actelion Pharmaceuticals US, Inc. | 2 | $32 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $23 |
| Bayer | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $19 |
| Abiomed | 1 | $18 |
| Biocompatibles, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$3,794 in reported general payments places this provider in the 55th percentile of 292 cardiovascular disease providers in Alabama.
Other cardiovascular disease in Florence
- Ajit NaiduFlorence$66K
- Ram SapkotaFlorence$11K
- Sean RhulandFlorence$9K
- Dennis ThomasMobile$894K
- David FienoAlabaster$421K
- Vikram AroraBirmingham$271K
- Jason ThompsonBirmingham$248K
- Michael WilenskyBirmingham$241K
- Mustafa AhmedBirmingham$218K
- Frederick GaskinBirmingham$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.